These findings point to the significance of ATF5 in the development of gliomas and suggest that ATF5-targeted therapy is a viable treatment option for glioblastoma, which is one of the deadliest forms of cancer and is characterized by a dismal prognosis [57]. This evidence concerns the gene ATF5 and glioblastoma.